You may not log in without verifying your email address.
Please check your email (including your spam email) for the Welcome message that was sent.
Lycorine·HCl, originally extracted from Lycoris radiata Herb, has been shown to inhibit viral protein synthesis and peptidyl transferase center. It has been demonstrated that Lycorine-HCL may act at the level of termination to regulate translation of RNA into protein. This compound has been reported to lower the mean arterial pressure in pentobar-bitone-anesthetized normotensive cats and rats. It has also been reported to antagonize the contractile effect of Methoxamine (sc-263468) and depress the hypersensitive effect of pheylephrineon rat anococcygeus muscle and rabbit aorta ring. Additionally, this agent was found to block α 1-adrenoceptors.
1. Kukhanova, M., et al. 1983. FEBS Lett. 160: 129-133. PMID: 6350039
2. Vrijsen, R., et al. 1986. J. Biol. Chem. 261: 505-507. PMID: 3001065
3. Chen, B.Y., et al. 1993. Zhongguo Yao Li Xue Bao. 14: 45-49. PMID: 8503287
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2020 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.